Cartesian Therapeutics (RNAC) Stock Chart & Stock Price History $11.30 +0.53 (+4.92%) Closing price 07/8/2025 04:00 PM EasternExtended Trading$11.83 +0.53 (+4.69%) As of 08:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cartesian Therapeutics Stock Price Performance The Cartesian Therapeutics (RNAC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 32.66%, with a year-to-date return of -36.91%. In the past month, the stock has increased 4.15%, reflecting recent market activity. As of the latest close, Cartesian Therapeutics traded at $11.30 with a market cap of $293.24 million and volume of 27,919 shares. Receive RNAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cartesian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.12%1 Month Performance+4.15%3 Month Performance-0.53%Year-To-Date Performance-36.91%1 Year Performance-32.66% RNAC Stock Chart for Wednesday, July, 9, 2025 RNAC Chart by TradingView Cartesian Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/08/2025$10.77$11.30+4.92%$11.46$10.8027,919 shs$293.24 million07/07/2025$11.18$10.77-3.62%$11.18$10.7137,029 shs$279.48 million07/04/2025$11.18$11.18$11.53$10.9552,381 shs$289.99 million07/03/2025$11.37$11.18-1.72%$11.53$10.9552,381 shs$289.99 million07/02/2025$10.89$11.37+4.41%$11.75$10.9549,808 shs$295.05 million07/01/2025$10.39$10.89+4.81%$11.20$10.2852,243 shs$282.60 million06/30/2025$10.68$10.39-2.72%$10.80$10.2851,193 shs$269.66 million06/27/2025$11.46$10.68-6.81%$11.70$10.01300,629 shs$277.15 million06/26/2025$10.76$11.46+6.51%$11.78$10.48102,918 shs$297.39 million06/25/2025$10.36$10.76+3.86%$10.87$10.1557,562 shs$279.22 million Get the Latest News and Ratings for RNAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cartesian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/24/2025$9.83$10.36+5.39%$10.40$9.7846,136 shs$268.84 million06/23/2025$9.76$9.83+0.72%$9.91$9.3734,035 shs$255.09 million06/20/2025$10.00$9.76-2.40%$10.10$9.6379,818 shs$253.27 million06/19/2025$10.00$10.00$10.40$9.7249,305 shs$259.50 million06/18/2025$9.79$10.00+2.15%$10.40$9.7249,305 shs$259.50 million06/17/2025$10.32$9.79-5.14%$10.56$9.7745,906 shs$254.09 million06/16/2025$10.42$10.32-0.96%$10.43$10.0431,084 shs$267.85 million06/13/2025$10.24$10.42+1.76%$10.44$10.0245,404 shs$270.44 million06/12/2025$10.41$10.24-1.63%$10.32$9.9041,608 shs$265.77 million06/11/2025$10.77$10.41-3.34%$11.26$10.4144,085 shs$270.18 million06/10/2025$10.85$10.77-0.74%$11.31$10.5150,572 shs$279.53 million06/09/2025$11.03$10.85-1.63%$11.48$10.5065,768 shs$281.60 million Related Companies AMPH Stock Chart DYN Stock Chart ABCL Stock Chart PAHC Stock Chart WVE Stock Chart ELVN Stock Chart VERV Stock Chart NTLA Stock Chart COLL Stock Chart AKBA Stock Chart Receive RNAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cartesian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RNAC) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cartesian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cartesian Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
